THANK YOU FOR SUBSCRIBING
Sterile pharmaceutical manufacturing is facing a convergence of regulatory expectations, contamination control requirements and emerging digital capabilities. Manufacturers are being asked to demonstrate stronger quality systems while adapting facilities and processes to new technologies. The PDA Aseptic Manufacturing Excellence Conference 2026 will examine these issues on October 14 and 15 at Pullman East Melbourne, Australia.
The two-day conference will bring together regulators, pharmaceutical manufacturers, microbiologists, engineers and quality professionals. Its opening plenary will address regulatory expectations for sterile manufacturing and contamination control, including inspection themes from Australia's Therapeutic Goods Administration. PDA also lists Wei Xia Ang of Cytiva among the key presenters, with the program examining how Contamination Control Strategies can connect environmental monitoring, aseptic process simulation, deviations, CAPA and quality risk management.
Contamination control will remain central throughout the program. Sessions will examine isolator technology, airflow management and environmental monitoring as manufacturers assess how facility systems can support consistent sterile production. Quality risk management will provide another layer, linking contamination controls with investigations, corrective actions and facility design decisions.
Digital technologies are also becoming part of the manufacturing discussion. The conference will examine artificial intelligence and advanced analytics in areas such as contamination investigations and environmental monitoring. These applications create opportunities to use manufacturing data more effectively while maintaining the quality controls required in regulated production environments.
Airflow assessment will provide another technical focus. Computational fluid dynamics and other visualization approaches can help manufacturers evaluate airflow behavior and environmental conditions. The program will also address anticipated PIC/S developments, keeping regulatory considerations connected to emerging engineering and monitoring practices.
Healthcare Tech Outlook is serving as a media partner because the conference aligns directly with its coverage of healthcare technology, medical innovation and digital transformation. The publication focuses on how healthcare organizations evaluate and scale technology-driven solutions, including data management and medical technologies. Editorial coverage can extend the Melbourne discussions by examining how digital tools are being incorporated into pharmaceutical manufacturing and quality systems.
The conference will conclude with a complimentary PDA site visit to Pfizer Australia and Pure Solutions Australia on October 16 for registered attendees, subject to available places. The combination of regulatory discussion, manufacturing expertise and technology-focused sessions provides a practical setting for examining how sterile production can adapt to changing requirements.
More in News